# A Study to Evaluate MAR002 for Acromegaly

> **NCT07641179** · PHASE2 · RECRUITING · sponsor: **Marea Therapeutics** · enrollment: 72 (estimated)

## Conditions studied

- Acromegaly

## Interventions

- **DRUG:** MAR002
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07641179
- **Lead sponsor:** Marea Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-07-23
- **Primary completion:** 2027-08
- **Final completion:** 2027-12
- **Target enrollment:** 72 (ESTIMATED)
- **Last updated:** 2026-09-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07641179

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07641179, "A Study to Evaluate MAR002 for Acromegaly". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07641179. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*